192 related articles for article (PubMed ID: 1658699)
1. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women.
Leather AT; Savvas M; Studd JW
Obstet Gynecol; 1991 Dec; 78(6):1008-10. PubMed ID: 1658699
[TBL] [Abstract][Full Text] [Related]
2. Amenorrhea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women.
Magos AL; Brincat M; Studd JW; Wardle P; Schlesinger P; O'Dowd T
Obstet Gynecol; 1985 Apr; 65(4):496-9. PubMed ID: 2984616
[TBL] [Abstract][Full Text] [Related]
3. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
4. Endometrial morphology and bleeding patterns as a function of progestogen supplementation.
Sturdee DW
Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153
[TBL] [Abstract][Full Text] [Related]
5. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
Odmark IS; Jonsson B; Bäckström T
Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178
[TBL] [Abstract][Full Text] [Related]
6. Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin.
Bewtra C; Kable WT; Gallagher JC
J Reprod Med; 1988 Feb; 33(2):205-8. PubMed ID: 2832598
[TBL] [Abstract][Full Text] [Related]
7. [HRT in post-menopausal women: endometrial histology and bleeding patterns].
Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM
Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870
[TBL] [Abstract][Full Text] [Related]
8. Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.
Hillard TC; Siddle NC; Whitehead MI; Fraser DI; Pryse-Davies J
Am J Obstet Gynecol; 1992 Jul; 167(1):1-7. PubMed ID: 1442905
[TBL] [Abstract][Full Text] [Related]
9. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
Archer DF; Pickar JH; Bottiglioni F
Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
[TBL] [Abstract][Full Text] [Related]
10. [Continuous postmenopausal estrogen-progesterone therapy].
Affinito P; Tommaselli GA; Morgera R; Rinaldi M; Di Mauro P; Nappi C
Minerva Ginecol; 1993 Mar; 45(3):77-85. PubMed ID: 8392669
[TBL] [Abstract][Full Text] [Related]
11. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
12. The role and use of progestogens.
Whitehead MI; Hillard TC; Crook D
Obstet Gynecol; 1990 Apr; 75(4 Suppl):59S-76S; discussion 81S-83S. PubMed ID: 2179792
[TBL] [Abstract][Full Text] [Related]
13. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
14. Regulation of estrogen/progestogen receptors in the endometrium.
Casper RF
Int J Fertil Menopausal Stud; 1996; 41(1):16-21. PubMed ID: 8673152
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
[TBL] [Abstract][Full Text] [Related]
16. A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate.
Neven P; Lunde T; Benedetti-Panici P; Tiitinen A; Marinescu B; de Villiers T; Hillard T; Cano A; Peer E; Quail D; Nickelsen T;
BJOG; 2003 Feb; 110(2):157-67. PubMed ID: 12618160
[TBL] [Abstract][Full Text] [Related]
17. Endometrial safety and bleeding with HRT: what's new?
Sturdee DW
Climacteric; 2007 Oct; 10 Suppl 2():66-70. PubMed ID: 17882676
[TBL] [Abstract][Full Text] [Related]
18. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
[TBL] [Abstract][Full Text] [Related]
19. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations.
Aylward M; Maddock J; Parker A; Protheroe DA; Ward A
Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584
[TBL] [Abstract][Full Text] [Related]
20. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
Rozenberg S; Ylikorkala O; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]